pelacarsen (AKCEA-APO(a)-LRx) - Novartis
HORIZON Outcomes Extended Analyses of Cardiovascular Outcomes With Pelacarsen Treatment in the Lp(a)Horizon Trial (AHA 2026) - Oct 8, 2026 - Pres time: Nov 7, 2026; 08:55 AM - 09:05 AM; Location: Center Stage‚ North Hall‚ Level 3; In-Person; No abstract available 
Late-breaking abstract • Cardiovascular
https://eppro01.ativ.me/web/page.php?page=session&project=AHA26&id=P16199
 
Leslie Cho; Steven Nissen
 
Oct 8, 2026
 
Prev Next